To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.
NCT ID: NCT00346554
Last Updated: 2014-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2006-04-30
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Behavioral Therapy for Insomnia Co-existing With COPD
NCT01973647
Internet-based Cognitive-behavioral Treatment for Insomnia in COPD Patients Undergoing Pulmonary Rehabilitation
NCT04700098
Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation
NCT04992676
Sleep Disordered Breathing in Patients With Chronic Heart Failure
NCT00863421
Epidemiology of Sleep-Disordered Breathing in Adults
NCT00005557
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PROTOCOL: To study the prevalence of insomnia in geriatric COPD patients who are enrolled in a pulmonary rehabilitation program.
I. OBJECTIVES OF THE STUDY
RATIONALE:
The goal for geriatric patients with COPD and enrolled in pulmonary rehabilitation programs is to improve the quality of life. COPD is known to be worse at night as are other respiratory problems such as CHF. Saturation is known to get worse nocturnally as well. Furthermore, these COPD rehabilitation patients tend to be older, and increasing age is associated with an increase in the incidence of sleep disorders. We suspect that there is an increase in the incidence of difficulty initiating and maintaining sleep in COPD patients. A preliminary study was done by the chest medicine specialist in our group, but the results were not comparable to national statistics and were inconclusive. We plan to further evaluate the geriatric COPD patients in pulmonary rehabilitation with initial screening questionnaire and diagnostic screening questionnaires (MMSE, Beck's Anxiety Inventory, Beck's Depression Inventory, and Epworth Sleepiness Scale).
GOALS:
* To determine the incidence and prevalence of insomnia (difficulty initiating sleep (DIS), and/or difficulty maintaining sleep (DMS) in the geriatric population with COPD in a rehabilitation program.
* To determine how many of these patients suffer from anxiety and/or depression.
HYPOTHESIS:
The incidence of insomnia (DIS and/or DMS), along with anxiety/depression is more prevalent in geriatric patients with COPD.
II. BACKGROUND MATERIAL According to the American Academy of Sleep Medicine (AASM), over a six-month period, 20 million Americans complained of insomnia.
COPD patients tend to have decreased total sleep time (32% reported total sleep time less than 6 hours). According to previous studies conducted, the following was reported:
* 15% reported to have insomnia;
* 28% reported poor quality sleep due to anxiety and/or depression;
* 12% reported \> 3 awakenings due to unknown origin.
RESULTS OF PILOT:
In the pilot study, a preliminary general (initial) questionnaire was used and will continue to be used as a tool for general screening purposes. And diagnostic questionnaires will be used, which are the following:
* Beck's Anxiety Inventory
* Beck's Depression Inventory
* Epworth Sleepiness Scale
* MMSE
III. DRUG INFORMATION
No drugs are used in this study protocol.
IV. INCLUSIONARY CRITERIA
Geriatric patients with COPD enrolled in the rehabilitation program with FEV1\<60%.
V. EXCLUSIONARY CRITERIA
Geriatric patients without a clear diagnosis of COPD. Geriatric patients whose FEV1\>60%. Geriatric patients who are unable to answer the questionnaire.
VI. RECRUITMENT PROCEDURES
Geriatric patients in the HUMC pulmonary rehabilitation program who consent to answer the questionnaire and with an FEV1\<60% will be enrolled.
VII. METHODOLOGY
Screening: Charts will be reviewed to see which patients meet the criteria of the study.
Informed Consent: If the patient is eligible for diagnostic screening, then an informed consent will be taken.
Randomization: None
Baseline evaluation: Geriatric patients will be asked the questions in the questionnaire.
Follow-up: If insomnia is found, patient will be referred for further treatment.
Withdrawal and Termination: The patient is unable to complete the questionnaire.
VIII. DISCOMFORT AND RISKS
No direct risks to the patient. Failure to follow-up in the clinic if indicated could be problematic.
IX. BENEFITS
Recognition and treatment of sleep problems in this group of patients will add to our understanding of problems in COPD.
X. CRITERIA FOR EVALUATING RESPONSE
No response anticipated from the study protocol.
XI. CONFIDENTIALITY
All results will be kept confidential. Data will only be used by the investigators. Data can be reviewed by the IRB at any time. HIPPA forms will be used for the patient's permission.
XII. PRIMARY INVESTIGATOR
Hormoz Ashtyani, M.D.
CO PRIMARY INVESTIGATOR
Susan Zafarlotfi Ph.D
GERIATRIC MEDICINE SPECIALIST
Knight R. Steel, M.D.
RESEARCH COORDINATOR
Mohammad Quadri, M.D. (MBA) RPSGT
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* rehabilitation program
* FEV1\<60%
Exclusion Criteria
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hackensack Meridian Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hormoz Ashtyani, MD
Role: PRINCIPAL_INVESTIGATOR
Hackensack Meridian Health
Susan Zafarlotfi, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Hackensack Meridian Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hackensack University Medical Center - Pulmonary Rehabilitation
Hackensack, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06.01.008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.